Comparison of the Ranger™ Paclitaxel-Coated PTA Balloon Catheter and Uncoated PTA Balloons in Femoropopliteal Arteries
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 105 participants.
Also called NCT02013193
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 105 participants
- Sponsor
- Hemoteq AG
- Registry
-
NCT02013193
-
- Other papers using this trial's data
- Six-Month Results From the Initial Randomized Study of the Ranger Paclitaxel-Coated Balloon in the Femoropopliteal Segment
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Austria, France, Germany
- Registry status
- Completed
Technical summary
Registry record NCT02013193. Randomized; single masking; primary purpose treatment. Start 2014-01-07 (actual); primary completion 2016-06-16 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of the Ranger™ Paclitaxel-Coated PTA Balloon Catheter and Uncoated PTA Balloons in Femoropopliteal Arteries
- Acronym
- RANGER-SFA
- Condition
- Peripheral Artery Disease
- Condition
- Claudication
- Condition
- Atherosclerosis
- Condition
- Arteriosclerosis
- Intervention (Device)
- Ranger DCB
- Intervention (Device)
- uncoated PTA balloon
- Lead sponsor
- Hemoteq AG
- Collaborator
- CERES GmbH
- Collaborator
- coreLab Black Forest GmbH
Record details
- Record id
cardio:ct-nct02013193- Content hash
d6cfa930191f5b0501512d38f1defa3cd93b610af972a5d4c40bf75e8a157635